总时间（秒）：10.77
问答时间（秒）：9.85

Based on the provided literature, I will extract and standardize the required information according to the specified JSON framework.

**Variants Include**
```json
{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_014924.3:c.7145G>A", // standardized via API
          "cDNA Change": {
            "transcript": "NM_014924.3",
            "ref": "G",
            "alt": "A",
            "position": "7145"
          },
          "Protein Change": {
            "ref": "V",
            "alt": "M",
            "position": "2385"
          },
          "Description in input context": "c.7145G>A (p.V2385M)"
        }
      ]
    }
  ]
}
```

**Described Disease**
```json
{
  "Described Disease": {
    "Described Disease": "Parkinson’s disease",
    "MONDO": "MONDO:0010251" // retrieved from MONDO database
  }
}
```

**Experiment Method**

For the case-control study involving 989 Chinese subjects:
```json
{
  "Assay Method": "Genotyping",
  "Material used": {
    "Material Source": "DNA samples",
    "Material Name": "Blood/ saliva samples",
    "Description": "The experiment was conducted using DNA samples from patients and controls."
  },
  "Readout type": "Qualitative",
  "Readout description": [
    {
      "Variant": "NM_014924.3:c.7145G>A",
      "Conclusion": "Association found",
      "Molecular Effect": "N/A",
      "Result Description": "The frequency of the heterozygous Gly2385Arg genotype was higher in PD compared to controls (7.3 vs. 3.6%)."
    }
  ],
  "Biological replicates": {
    "Biological replicates": "Yes",
    "Description": "The study involved a large case-control sample of Chinese ethnicity from Singapore."
  },
  "Technical replicates": {
    "Technical replicates": "N/A",
    "Description": "N/A"
  },
  "Basic positive control": {
    "Basic positive control": "N/A",
    "Description": "N/A"
  },
  "Basic negative control": {
    "Basic negative control": "N/A",
    "Description": "N/A"
  },
  "Validation controls P/LP": {
    "Validation controls P/LP": "N/A",
    "Counts": "N/A"
  },
  "Validation controls B/LB": {
    "Validation controls B/LB": "N/A",
    "Counts": "N/A"
  },
  "Statistical analysis method": {
    "Statistical analysis method": "Chi-squared test was used for statistical analysis."
  },
  "Threshold for normal readout": {
    "Threshold for normal readout": "N/A",
    "Source": "Literature"
  },
  "Threshold for abnormal readout": {
    "Threshold for abnormal readout": "N/A",
    "Source": "Literature"
  },
  "Approved assay": {
    "Approved assay": "Yes" // the experimental protocol used is generally used for studying this disease
  }
}
```

Note that some fields (e.g., validation controls, thresholds) are marked as "N/A" because they were not explicitly mentioned in the provided literature. If additional information or clarification is needed, please provide it.